Barclays PLC Aspira Women'S Health Inc. Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.3 - $0.41 $36 - $49	-120 Reduced 2.98%	3,910 $1,000
Q3 2022 Nov 03, 2022	SELL	$0.38 - $1.07 $160 - $452	-423 Reduced 9.5%	4,030 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.4 - $1.09 $3,153 - $8,592	-7,883 Reduced 63.9%	4,453 $3,000
Q1 2022 May 16, 2022	BUY	$0.88 - $1.81 $10,855 - $22,328	12,336 New	12,336 $13,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.